Prognostic value of FDG-PET SUV changes in cervical cancer following radiation therapy: a retrospective cohort study

Key Points

• Changes in SUV after treatment do not reliably predict survival outcomes in cervical cancer, indicating limitations in using this marker.
• Analysis involved a retrospective cohort of patients with locally advanced cervical cancer treated with radiation therapy.
• SUV changes observed in FDG-PET scans may not be suitable as standalone prognostic indicators, complicating treatment decisions.
• Further validation is needed to explore the applicability of SUV changes in clinical settings, as this study shows potential inconsistency.